7Baggers
 Published on: 2025-11-16 05:15:30  newser.com Sun, 16 Nov 2025 11:15:30 GMT
 published on: 2025-11-16 01:16:42  newser.com Sun, 16 Nov 2025 07:16:42 GMT
 Published on: 2025-11-15 23:55:40  newser.com Sun, 16 Nov 2025 05:55:40 GMT
 published on: 2025-11-13 12:05:20  newser.com Thu, 13 Nov 2025 18:05:20 GMT
 Sage Therapeutics discovers new GluN2A negative allosteric modulators  BioWorld MedTech Mon, 10 Nov 2025 13:00:00 GMT

Sage Therapeutics, Inc
(NASDAQ:SAGE) 

SAGE stock logo

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product p...

Founded: 2010
Full Time Employees: 675
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends